MS
Muthusamy Shanmugam (HEAD OF R&D, COO-NOVITIUM OPS) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in ANI Pharmaceuticals, Inc. (ANIP). The largest single filing was $9.0M of ANIP (100,000 sh across 2 lots, as filed), executed Aug 20 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$17.9M
shares × price, as filed
Last traded
Aug 21 2025
Filed Aug 22 2025
Median ADV $26.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $17.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 24 months
Most traded names
ANIPRecent filings
ANIPSALE
ANI Pharmaceuticals, Inc.
View filing →
$9.0M100,000 sh across 2 lots
Exec Aug 20 2025
Filed Aug 22 2025 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. View filing → $8.8M
100,000 sh across 2 lots
Exec Aug 14 2025
Filed Aug 18 2025 · 5:30 PM ET